JPWO2022159984A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022159984A5
JPWO2022159984A5 JP2023544446A JP2023544446A JPWO2022159984A5 JP WO2022159984 A5 JPWO2022159984 A5 JP WO2022159984A5 JP 2023544446 A JP2023544446 A JP 2023544446A JP 2023544446 A JP2023544446 A JP 2023544446A JP WO2022159984 A5 JPWO2022159984 A5 JP WO2022159984A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
set forth
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023544446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504390A5 (https=
JP2024504390A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/070326 external-priority patent/WO2022159984A1/en
Publication of JP2024504390A publication Critical patent/JP2024504390A/ja
Publication of JP2024504390A5 publication Critical patent/JP2024504390A5/ja
Publication of JPWO2022159984A5 publication Critical patent/JPWO2022159984A5/ja
Pending legal-status Critical Current

Links

JP2023544446A 2021-01-22 2022-01-24 抗her-2/trop-2構築物及びその使用 Pending JP2024504390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163140638P 2021-01-22 2021-01-22
US63/140,638 2021-01-22
PCT/US2022/070326 WO2022159984A1 (en) 2021-01-22 2022-01-24 Anti-her-2/trop-2 constructs and uses thereof

Publications (3)

Publication Number Publication Date
JP2024504390A JP2024504390A (ja) 2024-01-31
JP2024504390A5 JP2024504390A5 (https=) 2025-02-03
JPWO2022159984A5 true JPWO2022159984A5 (https=) 2025-02-03

Family

ID=80595406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023544446A Pending JP2024504390A (ja) 2021-01-22 2022-01-24 抗her-2/trop-2構築物及びその使用

Country Status (6)

Country Link
US (1) US20240101717A1 (https=)
EP (1) EP4281484B1 (https=)
JP (1) JP2024504390A (https=)
KR (1) KR20230147092A (https=)
CN (1) CN116917326A (https=)
WO (1) WO2022159984A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118804932A (zh) * 2022-01-26 2024-10-18 百奥赛图(北京)医药科技股份有限公司 抗her2/trop2抗体及其用途
KR20250075560A (ko) * 2022-07-15 2025-05-28 진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. 항-trop2 항체 및 이의 접합체
WO2024046455A1 (en) * 2022-09-01 2024-03-07 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Methods for preparing antibody-drug conjugates
AU2024248543A1 (en) * 2023-03-29 2025-10-09 Mythic Therapeutics, Inc. Trop2-binding proteins and uses thereof
AU2024350521A1 (en) * 2023-09-28 2026-03-26 Merck Sharp & Dohme Llc Use of an immunoconjugate for the treatment of non-small cell lung cancer
WO2025111445A1 (en) * 2023-11-21 2025-05-30 Convergent Therapeutics, Inc. Trop-2 radiopharmaceutical conjugate and uses thereof
WO2025191137A1 (en) * 2024-03-15 2025-09-18 Avidicure Ip B.V. Conjugates of trop2-specific antigen binding proteins and cytokines
WO2025254460A1 (ko) * 2024-06-07 2025-12-11 ㈜지아이이노베이션 Cd80 단백질 및 il-2 단백질을 포함하는 융합단백질 및 항체-약물 접합체를 포함하는 암 치료용 약학 조성물

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3817827A (en) 1972-03-30 1974-06-18 Scott Paper Co Soft absorbent fibrous webs containing elastomeric bonding material and formed by creping and embossing
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
DE3307869A1 (de) 1983-03-05 1984-09-06 Dragoco Gerberding & Co Gmbh, 3450 Holzminden Methylsubstituierte 1-((3-methylthio)-1-oxo-butyl)-cyclohex-2-ene, verfahren zu deren herstellung und deren verwendung als riech- und aromastoffe
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ATE68703T1 (de) 1984-02-08 1991-11-15 Cetus Corp Toxinkonjugate.
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US6121424A (en) 1991-11-25 2000-09-19 Enzon, Inc. Multivalent antigen-binding proteins
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
AU675929B2 (en) 1992-02-06 1997-02-27 Curis, Inc. Biosynthetic binding protein for cancer marker
US5698413A (en) 1993-05-05 1997-12-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating chemotherapeutic agents in vivo
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
CZ302070B6 (cs) 1998-04-21 2010-09-29 Micromet Ag Jednoretezcový multifunkcní polypeptid, polynukleotid, vektor obsahující tento polynukleotid, bunka transfekovaná tímto polynukleotidem, prostredek obsahující tento polypeptid, polynukleotid nebo vektor a jejich použití a zpusob identifikace aktiváto
US20030083263A1 (en) 2001-04-30 2003-05-01 Svetlana Doronina Pentapeptide compounds and uses related thereto
US6884869B2 (en) 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
WO2003074566A2 (en) * 2002-03-01 2003-09-12 Immunomedics, Inc. Rs7 antibodies
US7435797B2 (en) * 2002-04-10 2008-10-14 Genentech, Inc. Anti-HER2 antibody variants
US7393531B2 (en) * 2003-01-21 2008-07-01 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
US7498298B2 (en) 2003-11-06 2009-03-03 Seattle Genetics, Inc. Monomethylvaline compounds capable of conjugation to ligands
EP1817341A2 (en) 2004-11-29 2007-08-15 Seattle Genetics, Inc. Engineered antibodies and immunoconjugates
CN109906232B (zh) * 2016-09-23 2023-11-07 马伦戈治疗公司 包含λ轻链和κ轻链的多特异性抗体分子
CN109790215B (zh) * 2016-09-29 2023-06-30 北京韩美药品有限公司 异源二聚体免疫球蛋白构建体和其制备方法
WO2019222428A1 (en) * 2018-05-16 2019-11-21 Arbele Limited Composition of bispecific antibodies and method of use thereof
CN113543808A (zh) * 2019-01-04 2021-10-22 特瑞奥制药公司 多特异性蛋白质分子及其用途
CN116745316A (zh) * 2020-09-04 2023-09-12 武田药品工业有限公司 具有人血清白蛋白结构域的受限条件激活结合蛋白构建体

Similar Documents

Publication Publication Date Title
KR101287777B1 (ko) 가용성 cea에 대한 내성을 가지는 약학적 조성물
CN113321734B (zh) 抗cd47/抗pd-l1抗体及其应用
US20090028859A1 (en) Bispecific antibodies that bind to vegf receptors
CN101951953A (zh) 含抗grp78抗体作为有效成分的药物组合物
JP2026041845A5 (https=)
TW201026325A (en) Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
US20250034273A1 (en) Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof
JP2010509931A5 (https=)
US20230071019A1 (en) Compositions and methods for reducing off-target toxicity of antibody drug conjugates
KR20230132544A (ko) 신규한 항-그렘린1 항체
JP2024001073A5 (https=)
JP2020522488A5 (https=)
JP2023036612A (ja) プレクチン1結合性抗体およびその使用
CN111655287A (zh) Ildr2拮抗剂及其组合
WO2023071676A1 (zh) 一种抗her2/抗pd-l1双功能抗体及其应用
JP2024020436A5 (https=)
CN114829405A (zh) 抗bcma/抗4-1bb双特异性抗体及其用途
JPWO2022159984A5 (https=)
JPWO2022067262A5 (https=)
CN116284408A (zh) 结合人muc17的抗体、其制备方法及用途
WO2004003211A1 (en) Bispecific antibodies that bind to vegf receptors
JPWO2019212965A5 (https=)
JP2026512687A (ja) ヒト化l1cam抗体-薬物複合体
JPWO2021247769A5 (https=)
JPWO2023061505A5 (https=)